Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases

Immunology and Cell Biology

Volumn 94, Issue 10, 2016, Pages 994-999

  Jurczyluk, Julie ^a   Munoz, Marcia A ^a   Skinner, Oliver P ^a   Chai, Ryan C ^a   Ali, Naveid ^a   Palendira, Umaimainthan ^a,d   Quinn, Julian M W ^a   Preston, Alexandra ^a   Tangye, Stuart G ^a   Brown, Andrew J ^a   Argent, Elizabeth ^a,b   Ziegler, John B ^a,b   Mehr, Sam ^c   Rogers, Michael J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 2 PHOSPHONO 3 (3 PYRIDINYL)PROPANOIC ACID; FATOSTATIN; INTERLEUKIN 1BETA; ISOPRENOID; MEVALONATE KINASE; PROTEIN INHIBITOR; RAB PROTEIN; RAB14 PROTEIN; RAB1A PROTEIN; RAB7A PROTEIN; RAC PROTEIN; RAP PROTEIN; RHO FACTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; PYRIDINE DERIVATIVE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THIAZOLE DERIVATIVE;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLAST; MASS SPECTROMETRY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRENYLATION; QUANTITATIVE ANALYSIS; UPREGULATION; CASE REPORT; CELL LINE; CHILD; ENZYMOLOGY; FEMALE; ISOTOPE LABELING; MALE; METABOLISM; MEVALONATE KINASE DEFICIENCY; MONONUCLEAR CELL; PATHOLOGY; PRESCHOOL CHILD; PROTEIN PRENYLATION; TEMPERATURE;

CELL LINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERLEUKIN-1BETA; ISOTOPE LABELING; LEUKOCYTES, MONONUCLEAR; MALE; MEVALONATE KINASE DEFICIENCY; PROTEIN PRENYLATION; PYRIDINES; RAB GTP-BINDING PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TEMPERATURE; THIAZOLES;

EID: 84977160657     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.58     Document Type: Article

References (30)

1. Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 1999; 22: 175-177.
2. Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 1999; 22: 178-181.
3. Simon A, Kremer HP, Wevers RA, Scheffer H, De Jong JG, Van Der Meer JW, et al. Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 2004; 62: 994-997.
4. van der Burgh R, Ter Haar NM, Boes ML, Frenkel J. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol 2012; 147: 197-206.
5. Mandey SH, Schneiders MS, Koster J, Waterham HR. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat 2006; 27: 796-802.
6. Hoffmann GF, Wiesmann UN, Brendel S, Keller RK, Gibson KM. Regulatory adaptation of isoprenoid biosynthesis and the LDL receptor pathway in fibroblasts from patients with mevalonate kinase deficiency. Pediatr Res 1997; 41: 541-546.
7. Frenkel J, Rijkers GT, Mandey SH, Buurman SW, Houten SM, Wanders RJ, et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 2002; 46: 2794-2803.
8. Schneiders MS, Houten SM, Turkenburg M, Wanders RJ, Waterham HR. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. Arthritis Rheum 2006; 54: 2306-2313.
9. Marcuzzi A, Pontillo A, De Leo L, Tommasini A, Decorti G, Not T, et al. Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res 2008; 64: 177-182.
10. Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, et al. Structure-Activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 2001; 296: 235-242.
11. Coxon FP, Helfrich MH, van 't Hof RJ, Sebti SM, Ralston SH, Hamilton AD, et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 2000; 15: 1467-1476.
12. Montero MT, Hernandez O, Suarez Y, Matilla J, Ferruelo AJ, Martinez-Botas J, et al. Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells. Atherosclerosis 2000; 153: 303-313.
13. Kuijk LM, Beekman JM, Koster J, Waterham HR, Frenkel J, Coffer PJ. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood 2008; 112: 3563-3573.
14. Kuijk LM, Mandey SH, Schellens I, Waterham HR, Rijkers GT, Coffer PJ, et al. Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol 2008; 45: 2158-2165.
15. Massonnet B, Normand S, Moschitz R, Delwail A, Favot L, Garcia M, et al. Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes. Eur Cytokine Netw 2009; 20: 112-120.
16. Norton JT, Hayashi T, Crain B, Cho JS, Miller LS, Corr M, et al. Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1. J Immunol 2012; 188: 2977-2980.
17. Norton JT, Hayashi T, Crain B, Corr M, Carson DA. Role of IL-1 receptor-Associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates. Proc Natl Acad Sci 2011; 108: 11163-11168.
18. Mandey SH, Kuijk LM, Frenkel J, Waterham HR. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 2006; 54: 3690-3695.
19. Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 2002; 11: 3115-3124.
20. van der Burgh R, Nijhuis L, Pervolaraki K, Compeer EB, Jongeneel LH, van Gijn M, et al. Defects in mitochondrial clearance predispose human monocytes to interleukin-1beta hypersecretion. J Biol Chem 2014; 289: 5000-5012.
21. van der Burgh R, Pervolaraki K, Turkenburg M, Waterham HR, Frenkel J, Boes M. Unprenylated RhoA contributes to IL-1beta hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity. J Biol Chem 2014; 289: 27757-27765.
22. Ao X, Zou L, Wu Y. Regulation of autophagy by the Rab GTPase network. Cell Death Diff 2014; 21: 348-358.
23. Houten SM, Schneiders MS, Wanders RJ, Waterham HR. Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. J Biol Chem 2003; 278: 5736-5743.
24. Ali N, Jurczyluk J, Shay G, Tnimov Z, Alexandrov K, Munoz MA, et al. A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton. Small GTPases 2015; 6: 202-211.
25. Coxon FP, Helfrich MH, Larijani B, Muzylak M, Dunford JE, Marshall D, et al. Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem 2001; 276: 48213-48222.
26. Coxon FP, Ebetino FH, Mules EH, Seabra MC, McKenna CE, Rogers MJ. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo. Bone 2005; 37: 349-358.
27. Baron RA, Tavare R, Figueiredo AC, Blazewska KM, Kashemirov BA, McKenna CE, et al. Phosphonocarboxylates inhibit the second geranylgeranyl addition by Rab geranylgeranyl transferase. J Biol Chem 2009; 284: 6861-6868.
28. Gibson KM, Hoffmann G, Schwall A, Broock RL, Aramaki S, Sweetman L, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. J Lipid Res 1990; 31: 515-521.
29. Kamisuki S, Mao Q, Abu-Elheiga L, Gu Z, Kugimiya A, Kwon Y, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol 2009; 16: 882-892.
30. Stoffels M, Jongekrijg J, Remijn T, Kok N, van der Meer JW, Simon A. TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome. Rheumatology 2015; 54: 363-368.